Association between core mutations and annual decline rate of HBVDNA and HBsAg in chronic hepatitis B patients treated with nucleoside analogue

被引：0
|
作者：
Honda, Takashi [1 ]
Ishigami, Masatoshi [1 ]
Ito, Takanori [1 ]
Ishizu, Yoji [1 ]
Kuzuya, Teiji [1 ]
Fujishiro, Mitsuhiro [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med Gastroenterol & Hepatol, Nagoya, Aichi, Japan
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30488-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-215
引用
收藏
页码：E258 / E258
页数：1
相关论文
共 50 条
  • [1] Association between Core Mutations Induced By Interferon Therapy and Annual Decline Rate of Hbvdna in Chronic Hepatitis B Patients
    Honda, Takashi
    Ishigami, Masatoshi
    Ito, Takanori
    Ishizu, Yoji
    Kuzuya, Teiji
    Hirooka, Yoshiki
    HEPATOLOGY, 2018, 68 : 1233A - 1234A
  • [2] Relation between core mutations and HBVDNA, HBsAg decreasing rate in the patients with chronic hepatitis B
    Honda, Takashi
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Hayashi, Kazuhiko
    Hirooka, Yoshiki
    Goto, Hidemi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 367 - 368
  • [3] Is HBsAg Seroclearance Following Nucleoside Analogue Therapy Durable in Patients with Chronic Hepatitis B?
    Kim, Gi Ae
    Lim, Young-Suk
    An, Jihyun
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    HEPATOLOGY, 2012, 56 : 345A - 345A
  • [4] HBSAG DECLINE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH POTENT NUCS
    Moucari, Rami
    Bourliere, Marc
    Ripault, Marie-Pierre
    Castelnou, Corinne
    Mackiewicz, Vincent
    Dauvergne, Agnes
    Kahloun, Asma
    Serfaty, Lawrence
    Halfon, Philippe
    Martinot-Peignoux, Michelle
    Nicolas-Chanoine, Marie-Helene
    Marcellin, Patrick
    HEPATOLOGY, 2009, 50 (04) : 507A - 507A
  • [5] HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
    Kim, Gi-Ae
    Lim, Young-Suk
    An, Jihyun
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    GUT, 2014, 63 (08) : 1325 - 1332
  • [6] HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
    Kim, Jeong Han
    Choi, Yun Jung
    Moon, Hee Won
    Ko, Soon Young
    Choe, Won Hyeok
    Kwon, So Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (04) : 409 - 416
  • [7] Risk of Hepatocellular Carcinoma after HBsAg Seroclearance Associated with Nucleoside Analogue Therapy in Patients with Chronic Hepatitis B
    Kim, Gi Ae
    Han, Seungbong
    An, Jihyun
    Suh, Dong Jin
    Lim, Young-Suk
    HEPATOLOGY, 2013, 58 : 629A - 630A
  • [8] Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B
    Jun Lei
    Ying Wang
    Li-Li Wang
    Shao-Jun Zhang
    Wei Chen
    Zhi-Gang Bai
    Lv-Ye Xu
    Virology Journal, 10
  • [9] Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B
    Lei, Jun
    Wang, Ying
    Wang, Li-Li
    Zhang, Shao-Jun
    Chen, Wei
    Bai, Zhi-Gang
    Xu, Lv-Ye
    VIROLOGY JOURNAL, 2013, 10
  • [10] High rate of core promoter and precore mutations in patients with chronic hepatitis B
    Baqai, Sumbella F.
    Proudfoot, James
    Yi, Debbie H.
    Mangahas, Michael
    Gish, Robert G.
    HEPATOLOGY INTERNATIONAL, 2015, 9 (02) : 209 - 217
12345